Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association

NEXT STORY
G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting
PREV STORY
TLC Announces Part 1 Analysis of TLC590 Phase II Clinical Trial for Postsurgical Pain Management following Bunionectomy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association

NEXT STORY
G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting
PREV STORY
TLC Announces Part 1 Analysis of TLC590 Phase II Clinical Trial for Postsurgical Pain Management following Bunionectomy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Healthcare Asset Management Market Size 2021 | To Exhibit an Excellent CAGR of 28.9% and Hit USD 84,483.03 Million by 2027

author_avatar
NASDAQ Market News

Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of Directors

author_avatar
NASDAQ Market News

Orion Group Financial Statement documents 2017 and Corporate Governance Statement published

ORION CORPORATION           STOCK EXCHANGE RELEASE         26 FEBRUARY 2018 at 13.00 EET                       Orion Group ...

author_avatar
NASDAQ Market News